ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT
Clinical trials for ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New frontline attack on leukemia: CAR-T cells join chemo to boost survival
Disease control Recruiting nowThis study is testing whether adding a type of immunotherapy called CAR-T cell therapy to standard chemotherapy can better control a type of adult blood cancer (B-cell acute lymphoblastic leukemia). The goal is to see if this combination leads to longer survival with fewer relaps…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New CAR-T cell strategy aims to control tough leukemia with less chemo
Disease control Recruiting nowThis study is testing a new treatment plan for adults newly diagnosed with a specific, aggressive type of blood cancer called Philadelphia-positive acute lymphoblastic leukemia. The plan uses a combination of targeted pills, a short course of chemotherapy, and a one-time infusion…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for cancer patients with failing kidneys
Disease control Recruiting nowThis study is testing whether a powerful cancer treatment called CAR-T therapy can be safely given to people with moderate to severe kidney problems. Researchers are adjusting the dose of the chemotherapy drugs given right before the CAR-T cells to see if it reduces serious side …
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT
Phase: PHASE2 • Sponsor: Northside Hospital, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC